Artificial Intelligence In Oncology Market Forecast 2024-2033

Overview and Scope
Artificial intelligence in oncology refers to applying artificial intelligence (AI) technologies and techniques in cancer diagnosis, treatment, research, and patient care. The goal of AI in oncology is to improve outcomes for cancer patients by leveraging computational methods to identify patterns, predict outcomes, and support evidence-based decision-making across the continuum of cancer care.

Sizing and Forecast
The artificial intelligence in oncology market size has grown exponentially in recent years. It will grow from $1.33 billion in 2023 to $1.78 billion in 2024 at a compound annual growth rate (CAGR) of 33.7%. The growth in the historic period can be attributed to rising cancer incidence, data proliferation in healthcare, clinical trial optimization, demand for personalized medicine, efficiency in radiology and pathology..

The artificial intelligence in oncology market size is expected to see exponential growth in the next few years. It will grow to $5.63 billion in 2028 at a compound annual growth rate (CAGR) of 33.3%. The growth in the forecast period can be attributed to integration with electronic health records (ehr), expanded applications in treatment decision support, patient engagement and education, regulatory support and standardization.. Major trends in the forecast period include integration of natural language processing (nlp) in healthcare, utilization of ai in biomarker discovery, focus on explainable ai for clinical adoption, integration of ai in population health management, collaborations between ai developers and healthcare providers, advancements in predictive analytics..

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-oncology-global-market-report

Segmentation & Regional Insights
The artificial intelligence in oncology market covered in this report is segmented –

1) By Component: Software Solutions, Hardware, Services
2) By Treatment Type: Chemotherapy, Radiotherapy, Immunotherapy, Other Treatment Types
3) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Cancer Types
4) By Application: Cancer Detection, Drug Discovery, Drug Development, Other Applications
5) By End-Users: Hospitals, Diagnostic Centers, Pharmaceutical Companies, Research Institutes, Other End Users

North America was the largest region in the AI in oncology market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=13130&type=smp

Major Driver Impacting Market Growth
The rising incidence of cancer cases is expected to propel the growth of the AI in oncology market going forward. Cancer is a complex group of diseases characterized by the uncontrolled growth and division of abnormal cells in the body. The integration of AI into oncology has the potential to revolutionize cancer care by making it more precise, personalized, and efficient. For instance, in 2023, according to a report by the American Cancer Society Inc., a US-based voluntary health organization, the estimated number of new cancer cases increased from 1.8 million to 1.9 million. Therefore, the rising incidence of cancer cases is driving the growth of the AI in oncology market.

Key Industry Players

Major companies operating in the artificial intelligence in oncology market report are Azra AI, IBM Corporation, Siemens Healthcare GmbH, Intel Corporation, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI Inc., PathAI Inc., Median Technologies SA, Kheiron Medical Technologies Ltd., Hampton Research Inc., Tempus Labs Inc., Paige AI Inc., Prognos Health Inc., Enlitic, Inspirata Inc., Berg LLC, Proscia Inc., Prognos Health Inc., Deep 6 AI Inc., Ibex Medical Analytics, Nanox Imaging Ltd., Zebra Medical Vision, Globavir Biosciences Inc.

The artificial intelligence in oncology market report table of contents includes:

1. Executive Summary
2. Artificial Intelligence In Oncology Market Characteristics
3. Artificial Intelligence In Oncology Market Trends And Strategies
4. Artificial Intelligence In Oncology Market – Macro Economic Scenario
5. Global Artificial Intelligence In Oncology Market Size and Growth
.
.
.
31. Artificial Intelligence In Oncology Market Other Major And Innovative Companies
32. Global Artificial Intelligence In Oncology Market Competitive Benchmarking
33. Global Artificial Intelligence In Oncology Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Artificial Intelligence In Oncology Market
35. Artificial Intelligence In Oncology Market Future Outlook and Potential Analysis
36.Appendix

Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model